CardioOne earns private equity backing

Private equity company WindRose Health Investors has acquired Houston-based CardioOne.

Advertisement

CardioOne, which launched in 2023, helps cardiologists transition to value-based care with technology and administrative assistance. 

WindRose has committed up to $100 million in funds to facilitate growth for CardioOne, which plans to use the funds to expedite its next expansion phase, according to a March 4 news release from WindRose. 

CardioOne’s existing management team will retain business leadership and maintain active shareholding, according to the release.

In September, CardioOne partnered with three independent cardiology practices in New Jersey, Florida and Pennsylvania, according to a report from Global Data

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Cardiology

  • Women make up nearly half of participants in major structural heart disease trials, but they remain largely absent from the…

  • Cardiology is expanding increasingly into ASCs as CMS policy updates, advancements in cardiovascular innovation and population health concerns necessitate more…

Advertisement

Comments are closed.